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Abstract
Bacterial resistance and opportunistic human pathogens have become serious problems in 
hospitals, particularly those in which the dominant population consists of immunocompro-
mised elderly inpatients. Pseudomonas aeruginosa is a prevalent opportunistic human 
pathogen that causes acute pneumonia, cystic fibrosis, and septicemia, and it is also known 
to possess various mechanisms of natural and acquired resistance to antibiotics. 
Carbapenems have been used to treat infections caused by   -lactamase-producing gram-
negative bacteria including P. aeruginosa, but  metallo- -lactamase (MBL) can render 
carbapenems ineffective, and so action is required to prevent the development of strains 
that produce MBL. Between September 2010 and August 2011, 8 multidrug-resistant P.
aeruginosa (MDRP) strains were isolated from pressure ulcer, urine, or expectoration or 
aspiration sputum samples of patients with different infections in a hospital in Osaka 
Prefecture, Japan. After confirming MBL production, we identified 5 strains that produced 
IMP-type MBL. The strain variations of isolated MDRP were determined by multiple-
locus variable-number tandem repeat analysis. Because the 5 IMP-type MBL-producing 
strains were of the same genotype, it was suggested that the infection had spread within 
the wards. The remaining non-MBL-producing MDRP strains were also of the same 
genotype, but antimicrobial breakpoint ests revealed that they were not exactly the same, 
and the wards from which they had been isolated were not close to each other. Therefore, 
more accurate typing of the non-MBL-producing enotype group is required to determine 
whether diffusion between the wards had occurred.
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INTRODUCTION
 Bacterial resistance has become a serious 
worldwide medical issue. In Japan, with the rapid 
increase in the elderly population, an increased in-
cidence of impaired resistance to infection is ex-
pected in elderly inpatients. Recently, large-scale 
infections within hospitals have been reported, 
and the data have been compiled into a database 
(http: //www. nih-janis. jp/section/index. html).
Therefore, the expansion of preventive measures 
against multidrug-resistant opportunistic patho-
gens such as Pseudomonas aeruginosa, Acineto-
bacter spp., and  Klebsiella  pneumoniae has be-
come especially important. 
 In particular, P. aeruginosa is a prevalent oppor-
tunistic human pathogen that causes acute pneu-
monia, cystic fibrosis, and septicemia in immuno-
compromised individuals, including elderly pa-
tients with chronic conditions (Govan and Deretic,
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1996). P. aeruginosa is also known to possess 
various mechanisms of natural and acquired 
resistance to antibiotics (Aloush et al., 2006), and 
the strains that are resistant to carbapenems, 
aminoglycosides, and fluoroquinolones are defined 
as multidrug-resistant P. aeruginosa (MDRP), 
according to the Infectious Diseases Control Law 
in Japan. Carbapenems have been used to treat 
infections caused by ,8-lactamase-producing gram-
negative bacteria, but bacterial strains that 
produce  metallo- -lactamase (MBL), which ren-
der almost all broad-spectrum   -lactams and 
carbapenems ineffective, have been detected with 
the use of carbapenems (Senda et  al., 1996a). The 
MBL genes are found in integrons frequently 
located in plasmids or transposons, which contrib-
ute to their dissemination (Fluit and Schmitz, 
1999). 
 P. aeruginosa thrives in soil and aqueous envi-
ronments, including areas around nursing-station 
sinks and bathrooms of medical facilities, where it 
survives because of environmental adaptations 
that allow it to utilize a variety of nutrients 
(Nishijyo et  al., 2001). Because the spread of infec-
tion may occur through various routes, it is impor-
tant to evaluate the spread of the same strain be-
tween patients. Methods frequently used to iden-
tify the variety of P. aeruginosa strains include 
multi-locus sequence typing (Curran et al., 2004), 
pulsed-field gel electrophoresis (Romling et al., 
2000), and multiple-locus variable-number tandem 
repeat analysis (MLVA) (Onteniente et al., 2003), 
which initially used 7 sets of polymorphic tandem 
repeat loci. More recently, modifications of the 
MLVA method using 15 sets of repeat loci for 
accurate typing (Vu-Thien et al., 2007) and 4 sets 
of repeat loci (MLVA-4) for simple and easy de-
tection (Hayakawa et  al., 2009) have been devel-
oped.
(IMP), amikacin, and ciprofloxacin are   16,  
32, and  4   g/mL, respectively, are defined 
as MDRP.  PA01 is a standard strain of P. 
aeruginosa for which the complete genomic 
sequence is available (Stover et al., 2000). 
 All strains were cultured at 37°C in Mueller-
Hinton medium (Oxoid, Sunnyvale, USA) supple-
mented with antibiotics when appropriate.
DNA techniques 
 DNA purification and other DNA manipulations 
were conducted as previously described (Nakada 
and Itoh, 2002; Sambrook et al., 2001). A polyme-
rase chain reaction (PCR) was performed with 
KOD-plus DNA polymerase (Toyobo Biochemi-
cals, Osaka, Japan) in a GeneAmp PCR System 
2700 thermal cycler (Applied Biosystems, Foster 
City, USA) under the reaction conditions recom-
mended by the supplier.
Antibiotic susceptibility test 
 Antimicrobial breakpoint ests were conducted 
by FALCO Biosystems Ltd. using the MicroScan 
WalkAway Plus fully automated instrument. Iso-
lates were evaluated for susceptibility to 
piperacillin, ceftazidime, cefozopran, imipenem, 
minocycline, amikacin, and ciprofloxacin and 
categorized as susceptible  (S), intermediate (I), or 
resistant (R) according to the antibiotic breakpoint 
guidelines of the Clinical and Laboratory Stan-
dards Institute (Clinical and Laboratory Stan-
dards Institute, 2006) for P. aeruginosa.
Screening of MBL producers by SMA test 
 The screening of all MDRP isolates to detect 
MBL producers was carried out using a sodium 
mercaptoacetic acid (SMA) (Eiken, Tokyo, Japan) 
disk method, with Kirby-Bauer disks (Eiken) of 
ceftazidime and SMA.
MATERIALS AND METHODS
Bacterial isolates and growth conditions 
 Between September 2010and August 2011, P. 
aeruginosa strains were isolated from pressure 
ulcer, urine, or expectoration or aspiration sputum 
samples of patients with different infections in a 
hospital (approximately  1,000 beds); the dominant 
population in this hospital in Osaka Prefecture, 
Japan consists of immunocompromised elderly 
inpatients. Genus classification of the strains was 
performed using the MicroScan WalkAway Plus 
(Siemens, Munich, Germany) fully automated 
instrument. Isolated P. aeruginosa for which 
minimum inhibitory concentrations of imipenem
Immunochromatographic detection of IMP-type MBLs 
 The IMP-type MBLs were detected by im-
munochromatography (Quick Chaser IMP; 
Mizuho Medy, Saga, Japan), in which colloidal 
gold-labeled anti-IMP rat monoclonal antibodies 
were applied to a test strip, in all SMA-positive 
isolates.
PCR detection of  blaimp 
 The IMP-type MBL genes  (blaimp) were 
detected by PCR in all isolates for which the im-
munochromatographic method yielded positive 
results. According to the PCR detection method 
by Shinoda et al. (2006), primers (forward 5'  -
CTACCGCAGCAGAGTCTTTG-3' and reverse
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5' -GTGGCITGAACCTTACCGTC-3') were pre-
pared and the amplification reaction was carried 
out under the following cycling conditions: 94°C 
for 2  min; 30 cycles of 94°C for 30 sec, 57°C for 1.5 
 min, and 68°C for 1.5  min; and a final extension at 
68°C for 2  min. The PCR products were deter-
mined by 2.0% agarose gel electrophoresis. For 
the positive control of  blaimp, we used a  blaimp-1- 
possessing plasmid that our laboratory had de-
tected previously.
Genotyping by MLVA-4 
 The strain variations of all isolated MDRP were 
determined by MLVA-4 (Hayakawa et al., 2009). 
The PCR primers used to amplify 4 sets of 
polymorphic tandem repeat loci and the amplicon 
size and repeat copy number of  PA01 are listed in 
Table 1. PCR conditions for MLVA-4 were as 
follows: 94°C for 2  min; 30 cycles of 96°C for 20 sec, 
64°C for 30 sec, and 68°C for 1.5  min; and a final 
extension at 68°C for 2  min. The fragment size of 
the PCR products was determined by 2.0-4.0% 
agarose gel electrophoresis.
RESULTS
Isolated strains of MDRP 
 Within 1 year, we identified 8 patients at the 
hospital who had developed MDRP infection, and 
we obtained clinical isolates from pressure ulcer,
urine, or expectoration or aspiration sputum sam-
ples (Table 2). The patients included those on ger-
iatric chronic-stage wards (A and C), specific 
disease wards (B), and an acute-phase ward (D). 
The antimicrobial breakpoint est showed that all 
8 isolates were amikacin-, imipenem-, and 
ciprofloxacin-resistant; moreover, AUH-55, AUH-
56, AUH-59, AUH-63, AUH-66, and AUH-68 
strains were resistant o all antibiotics tested. Of 
the remaining 2 strains, both isolated from ward C 
patients, AUH-57 was intermediate against 
cefozopran and AUH-62 was intermediate and 
susceptible to ceftazidime and cefozopran, respec-
tively.
Detection of MBL 
 Of the 8 strains evaluated by the screening 
tests using disks containing SMA, 5 strains 
(AUH-55, AUH-56, AUH-59, AUH-66, and AUH-
68) appeared to produce MBL (Table 2). The 
SMA-positive strains were also confirmed to 
produce IMP-type MBL by immunochromatogra-
phy (Table 2). However, of the 5 IMP-type MBL-
producing strains,  b/aimp was not amplified by the 
common specific PCR method (data not shown).
MLVA-4 of isolated MDRPs 
 MLVA-4 of the 8 clinically isolated MDRPs 
revealed the same electrophoreric pattern for 
AUH-55, AUH-56, AUH-59, AUH-66, and AUH-
Table 1 PCR primers for the detection of tandem repeat loci
Locus name Associated ORF Primer Oligonucleotide sequence (5'-3') Amplicon size bp* 
(repeat copy no.)
ms-61
ms-77
ms-142
ms-172
pscP
pcoA 
PA3463
PA4541
 PscP-L 
 PscP-R 
PcoA-L 
PcoA-R 
PA3463-L 
PA3463-R 
PA4541-L 
PA4541-R
CTTGCCGTGCTACCGATCC 
CCCCCATGCCAGTTGC 
GCGTCATGGTCTGCATGTC 
TATACCCTCTTCGCCCAGTC 
AGCAGTGCCAGTTGATGTTG 
GTGGGGCGAAGGAGTGAG 
GGATTCTCTCGCACGAGGT 
TACGTGACCTGACGTTGGTG
127 (12)
422 (4) 
890 (7)
789 (12)
*Corresponding to P
. aeruginosa  PA01
Table 2 Specimens, antimicrobial breakpoints, and MBL detection of MDRP isolates
Strain        Hospital 
         ward Specimens
Breakpoint
 PIPC CAZ  CZOP  IPM MINO AMK CPFX
SMA 
test
IC-IMP 
 test
AUH-55 
AUH-56 
AUH-57 
AUH-59 
AUH-62 
AUH-63 
AUH-66 
AUH-68
A 
B 
C 
B 
C 
D 
B 
B
 pressure ulcer 
     urine 
     urine 
     urine 
aspiration sputum 
 expectoration 
     urine 
     urine
R 
R 
R 
R 
R 
R 
R 
R
R 
R 
R 
R 
R 
R
R 
R 
S 
R 
R 
R
R 
R 
R 
R 
R 
R 
R 
R
R 
R 
R 
R 
R 
R 
R 
R
R 
R 
R 
R 
R 
R 
R 
R
R 
R 
R 
R 
R 
R 
R 
R
A and C represent geriatric chronic-stage wards, B represents specific disease wards , and D represents an acute-phase ward. 
PIPC,  piperacillin; CAZ,  ceftazidime; CZOP,  cefozopran;  IPM,  imipenem; MINO , minocycline; AMK,  amikacin; CPFX, ciprofloxacin; 
IC-IMP, IMP-type MBL immunochromatography.
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 bp 
 200 
100
A
 600   
500 
400
    
  B
 300 
200
100
C
1,000
900
800
M 1 2 3 4 5 6 7 8 M
D
A, ms-61; B,  ms-77; C,  ms-142;  D:  ms-172. Lane M, 100-bp DNA marker: 
 1, AUH-55; 2, AUH-56; 3, AUH-57; 4, AUH-59; 5, AUH-62; 6, AUH-63; 
 7, AUH-66; 8, AUH-68 
Figure 1 Electrophoresis for the MLVA-4 of the isolated 
        MDRP strains
Table 3 Genotypes of the reference strain  PA01 and isolated 
      MDRP strains
Strain       Hospital 
        ward
Allele at the following locus maker
ms-61  ms-77 ms-142 ms-172
 PA01 
AUH-55 
AUH-56 
AUH-57 
AUH-59 
AUH-62 
AUH-63 
AUH-66 
AUH-68
A 
B 
C 
B 
C 
D 
B 
B
12 
13 
13 
10 
13 
10 
10 
13 
13
4 
6 
6 
3 
6 
3 
3 
6 
6
7 
1 
1 
1 
1 
1 
1 
1 
1
12 
13 
13 
13 
13 
13 
13 
13 
13
68 strains (Figure 1). From the repeat copy num-
ber of each locus deduced by the amplicon size, 
this group was identified as genotype 13-6-1-13 
(Table 3). In the same way, AUH-57, AUH-62, 
and AUH-63 showed the same electrophoreric 
pattern and were identified as genotype  10-3-1-
13. From these results, it appears that only 2 
strain types were isolated from 8 different pa-
tients within 1 year.
DISCUSSION
 Over the course of 1 year, 8 patients at the 
hospital were found to have an MDRP infection, 
and the MDRP detection rate (number of newly 
infected patients/total number of hospitalized pa-
tients) was 0.39%. Because of the high number of 
chronic-stage elderly patients who are hospital-
ized, stringent nosocomial infection measures are 
necessary. 
 After confirming the presence of MDRP based
on a drug sensitivity test and MBL production by 
a SMA test, we could divide the bacterial strains 
into 2 groups: SMA-positive (AUH-55, AUH-56, 
AUH-59, AUH-66, and AUH-68) and SMA-nega-
tive (AUH-57, AUH-62, and AUH-63). The SMA-
positive group consisted of highly resistant strains 
that also produced IMP-type MBL, and all of these 
strains showed resistance to all antibiotics that we 
examined. However, we were unable to amplify 
the domain for  blaIMP by the general  blaIMP -
detection PCR (Shinoda et  al., 2006; Senda et al., 
1996b). These results indicate that the SMA-
positive strains maintain the production of IMP-
type MBL that cannot be detected by the primers. 
With respect to the IMP-type MBL, 48 kinds have 
now been confirmed, and this number is increas-
ing annually (http: //www. lahey. org/Studies/). 
Among these, there are alleles that cannot be 
amplified by the general  blaIMP -detection PCR, 
such as  blaIMp-7 (Koh et  al., 2004). Furthermore, 
an unidentified allele that cannot be amplified by 
the PCR may be present. Subsequently, we plan 
to use touch down PCR or multiplex PCR based on 
the  blaIMP sequence diversities, and to confirm the 
findings by complete sequencing of the  blaIMP 
detected this time. 
 Strain identification with the MLVA-4 method 
revealed that all 5 SMA-positive strains had the 
same genotype (13-6-1-13), and the antimicrobial 
breakpoint tests showed that the 5 strains were 
all similarly resistant (Table 2). These results 
indicate that the spread of infection on the B ward 
had occurred via the same genotype strain. The 
MVLA-4 method also revealed that the 3 SMA-
negative strains obtained from the patients on the 
C and D wards were also all of the same genotype 
(13-6-1-13), but, according to the antimicrobial 
breakpoint tests, the 3 strains were not exactly 
the same (Table 2). It is noteworthy that, in the 
hospital, the C and D wards are not close to each 
other. Because MLVA-4 is a simplified detection 
method, detailed analysis using MLVA-15 or 
pulsed-field gel electrophoresis is necessary to 
conclude that diffusion spreads on the C and D 
wards.
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